ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway Trial.

Clin Cancer Res · 2025 · PMC7618057 · PMID 40512191

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The Guardant360 Response algorithm, based on Zhang et al, 27 also identified patients with low ctDNA levels who had numerically better PFS and OS, which did not reach statistical significance due to small numbers.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.